First Covid Drug Approved in US and AT&T Up on Earnings 💊

First Covid Drug Approved in US and AT&T Up on Earnings

Gilead – GILD

The FDA approved Gilead antiviral drug Remdesivir as a treatment for the coronavirus yesterday causing the company’s stock price to jump more than 7% in after-hours trading. The drug was previously given emergency use authorization and was shown to shorten recovery of some hospitalized patients. However, a WHO study recently revealed that the drug does little to nothing to prevent death in hospitalized patients.

Still, this is a big deal because the drug is the first to have full FDA approval to treat the disease. With its current cost of $3,120 per five-day treatment, Gilead is certainly happy to finally have their drug approved.

AT&T – T

The company met its third quarter earnings expectations and exceeded revenue projections when it reported yesterday morning. Investors were also surprised to see the company post double the phone subscriber growth that its competitor Verizon reported.

Another promising aspect of AT&T’s third quarter was a 1.7 million person increase in subscribers to streaming services HBO and HBO Max. However, it’s still not all great for the company as many of its brands continue to struggle. DirecTV continues to be challenged by cord cutting, and WarnerMedia has been hurt by a struggling movie theater industry.

I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.

Share:
More Posts
OPEC’s Decision 🛢
1 December, 2023

OPEC leaders just hosted an important late-November meeting that may signal a change in strategy.

Load More
Get your daily Invstr Crunch

Get the market news and updates you need, delivered to your inbox or available on our daily podcast.

Facebook Twitter Youtube Instagram Snapchat Tiktok
learn
products
plan
Who we are
blog

Risk Disclosure:

Invstr is not a bank and banking services are provided by Vast Bank, N.A.

Brokerage and Banking services are currently only available to U.S. residents.

Invstr app and web services are provided by Invstr Ltd. Advisory services are provided by Invstr Financial LLC, an investment adviser registered with the Securities Exchange Commission (SEC) details of which can be obtained here. Securities brokerage and custody services are provided by Apex Clearing, a broker dealer registered with the SEC and a member of FINRA and SIPC. There is no bank guarantee on securities and securities may lose value.

Investing involves risk and can lead to losses. Past performance does not guarantee future results.

Invstr app and web services are provided by Invstr Ltd. Invstr+ advisory services are provided by Invstr Financial LLC, an investment adviser registered with the Securities Exchange Commission (SEC). Securities brokerage and custody services are provided by Apex Clearing, a broker dealer registered with the SEC and a member of FINRA and SIPC. There is no bank guarantee on securities and securities may lose value. Vast Bank N.A. a nationally chartered bank and member of the FDIC, provides the banking products, including the products and services related to digital asset accounts. As with any asset, the value of Digital assets can go up or down and there can be a substantial risk that you lose money buying or holding digital assets. You should carefully consider whether trading or holding Digital assets is suitable for you in light of your financial condition. Your digital account does not support wallet to wallet transferring of your digital assets (i.e. cryptocurrencies) outside the platform. Any Digital Assets in your digital asset account are not insured by any government entities, including but not limited to FDIC or SIPC. The Invstr Visa® Debit Card is issued by Vast Bank, N.A. pursuant to a license from Visa U.S.A Inc and may be used everywhere Visa debit cards are accepted. Invstr Ltd, Invstr Financial LLC and Invstr Securities Ltd are subsidiaries of Marketspringpad Holdings (collectively “Invstr”) and Invstr is solely responsible for the application services and website content.

Watchlists provided when users first access the service are not a recommendation to invest. Instead they are provided to help users better navigate the service. Users are free to edit and create their own watchlists. From time to time, Invstr will suggest instruments solely based on an individual’s interest and the interest levels of the Invstr community. The statistical and portfolio builder models generated by Invstr do not reflect actual investment results and are not guarantees of future results. Comments provided by Invstr leaders, influencers or members of the Invstr Community are not recommendations and should not be construed as such. Invstr does not endorse the content or the positions posted by them. Their investment approach, and that of the models provided by Invstr, may be different from yours and may not be appropriate for you.